Video Library

Half of patients who have a stem cell transplant using donor cells (an allogeneic transplant) develop chronic graft-versus-host-disease (GVHD). In up to a third of those patients, GVHD affects the mouth, esophagus, stomach and/or GI tract. GVHD can also affect the liver and/or pancreas. This presentation describes the symptoms and treatment options for GI and liver GVHD.

Fatigue is the most common symptom associated with cancer treatment and it is caused by many factors. This presentation discusses factors that contribute to fatigue, and how an individualized exercise program can be an effective strategy to fight fatigue.

Patients who have had a stem cell transplant have a higher risk of developing a second cancer than the general population. The risk of developing a second cancers increases over time. Life-long surveillance and testing is important to catch any second cancer early, when treatment is most effective.

Ask the Transplant Experts - Session One Presenters: Mohamed Hegazi MD, UofL Brown Cancer Center Gerhard Hildebrandt MD, University of Kentucky Blood and Marrow Transplantation and Cellular Therapy Program Navneet

After a pediatric bone marrow transplant, patients are at risk of developing new transplant-related health problems. These problems may not appear until later in life. This presentation discusses the potential complications, available treatments, and the importance of a healthy lifestyle ongoing monitoring to detect health issues early, when treatment is most effective.

The chemotherapy and/or radiation given to patients before a stem cell transplant compromise immunity and leave patients vulnerable to infections. This presentation describes major infection risks and effective responses to them. Many thanks to Takeda Pharmaceutical Company whose support, in part, made this presentation possible.

Stem cell transplant recipients have an increased risk of developing sexual problems and infertility after transplant. In men, erectile dysfunction and low testosterone are the most common sexual problems reported, and both are very treatable.

Transplant does not take away a woman’s sexuality but it can cause sexual difficulties after transplant. There are a variety of effective treatments. Good communication between partners is one important ingredient in resolving sexual difficulties after transplant.

People may experience a variety of lung problems in the first several years after transplant. This presentation describes both rare and common lung problems and the available remedies to treat them.

COVID-19 can cause serious illness and death. This presentation discusses the the most effective strategies to prevent a COVID infection, and the pros and cons of medications available to treat transplant recipients who do become infected. Many thanks to Takeda Pharmaceutical Company whose support, in part, made this workshop possible.

Stem cell transplants in older patients have, historically, had lower success rates than those in younger patients. This presentation describes several new promising strategies to improve transplant outcomes and survival rates in older patients. Many thanks to Pharmacyclics, an AbbVie Company, and Janssen Biotech, Inc., Jazz Pharmaceuticals and Omeros Corporation, whose support, in part helped make this workshop possible.

Ovarian failure, estrogen deficiency, decreased sex drive, infertility and vaginal graft-versus-host disease are a concern for many women after a stem cell transplant. This presentation discusses what causes these problems and treatment options, particularly for women with vaginal graft-versus-host disease (GVHD).